FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Advanced Accelerator Applications Pluvicto Recall

Pluvicto, 1000 MBq/mL (27 mCi/mL), lutetium, LU 177, vipivotide tetraxetan injection, S…

Advanced Accelerator Applications USA, Inc. · Millburn, NJ

Risk level
Class II
Reported by FDA
Oct 9, 2024
Recall ID
D-0007-2025
Check your lot numberHow we source this data

Summary

Advanced Accelerator Applications recalled Pluvicto starting Sep 23, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0007-2025 on Oct 9, 2024. Reason: CGMP deviations. Status: Ongoing.

Why it was recalled

CGMP deviations

Product description

Pluvicto, 1000 MBq/mL (27 mCi/mL), lutetium, LU 177, vipivotide tetraxetan injection, Single-dose vial, Sterile, Manufacturer Advanced Accelerator Applications, 57 E. Willow Street, NJ 07041, Millburn USA. NDC 69488-0010-61

Lot numbers, UPCs & expiration codes

Lot#: LPS240919B-16, 24-Sep-2024 Lot#: LPS240920B-16, 25-Sep-2024 Lot#: LPS240920C-16, 25-Sep-2024

Where it was sold

FL, MA, NJ, NY, PA, and VA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0007-2025
Classification
Class II
Status
Ongoing
Recall initiated
Sep 23, 2024
FDA report date
Oct 9, 2024
Quantity
99 doses
Recall type
Voluntary: Firm initiated
Recalling firm
Advanced Accelerator Applications USA, Inc.

Original FDA data

Every field from FDA enforcement report D-0007-2025, exactly as published.

Show all FDA fields
City
Millburn
State
NJ
Status
Ongoing
Country
United States
Event ID
95420
Address
57 E Willow St
Code information
Lot#: LPS240919B-16, 24-Sep-2024 Lot#: LPS240920B-16, 25-Sep-2024 Lot#: LPS240920C-16, 25-Sep-2024
Postal code
07041-1416
Report date
Oct 9, 2024
Product type
Drugs
Recall number
D-0007-2025
Classification
Class II
Recalling firm
Advanced Accelerator Applications USA, Inc.
Product quantity
99 doses
Reason for recall
CGMP deviations
Voluntary / mandated
Voluntary: Firm initiated
Product description
Pluvicto, 1000 MBq/mL (27 mCi/mL), lutetium, LU 177, vipivotide tetraxetan injection, Single-dose vial, Sterile, Manufacturer Advanced Accelerator Applications, 57 E. Willow Street, NJ 07041, Millburn USA. NDC 69488-0010-61
Distribution pattern
FL, MA, NJ, NY, PA, and VA
Recall initiation date
Sep 23, 2024
Initial firm notification
Letter
Center classification date
Oct 3, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0007-2025, published Oct 9, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls